Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Hormon Receptor Positive Breast Cancer · Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Städtisches Klinikum Dessau, Dessau, Germany

  • Hospital General Universitario Dr. Balmis, Alicante, Spain

  • Hospital Clínic Barcelona, Barcelona, Spain

  • Hospital Dexeus, Barcelona, Spain

  • Institut Català d'Oncologia Girona - ICO Girona, Girona, Spain

  • HU Virgen de las Nieves, Granada, Spain

  • Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, Spain

  • Hospital Universitario de León, León, Spain

  • Beata Maria Ana, Madrid, Spain

  • Hospital Ramón y Cajal, Madrid, Spain

  • Hospital Regional Universitario de Málaga, Málaga, Spain

  • Sant Joan de Reus, Reus, Spain

  • H Quirónsalud Sagrado Corazón, Seville, Spain

  • Hospital Universitario y Politécnico de La Fe, Valencia, Spain

  • HUAV Valencia, Valencia, Spain

  • IVO - Instituto Valenciano de Oncología, Valencia, Spain